Provention bio to present at the cantor fitzgerald virtual global healthcare conference 2021

Red bank, n.j., sept. 23, 2021 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in a fireside chat presentation at the cantor fitzgerald virtual global healthcare conference 2021 on wednesday, september 29, 2021 at 3:20 pm e.t.
PRVB Ratings Summary
PRVB Quant Ranking